期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Clinical applications of fibroblast activation proteintargeted theranostics in oncologic and nononcologic disease:Current status and future directions 被引量:1
1
作者 Hao Fu Wei Guo +2 位作者 Jingxiong Huang Hua Wu Haojun Chen 《iRADIOLOGY》 2023年第4期340-361,共22页
Quinoline-based fibroblast activation protein(FAP)inhibitor(FAPI)-based positron emission tomography(PET)imaging and radioligand therapy(RLT)are being investigated for use in a wide variety of diseases,and recent resu... Quinoline-based fibroblast activation protein(FAP)inhibitor(FAPI)-based positron emission tomography(PET)imaging and radioligand therapy(RLT)are being investigated for use in a wide variety of diseases,and recent results have been promising.This review summarizes the current status of FAPI radiopharmaceuticals in PET imaging of malignant tumors and benign conditions and compares their diagnostic efficacy with ^(18)F-fluorodeoxyglucose.In addition,we summarize the previously published FAP-targeted RLT data and discuss its current clinical use and future potential.Our qualitative summary can inform future research directions,medical guidelines,and optimal clinical decision-making. 展开更多
关键词 FAPI-PET fap-targeted radioligand therapy fap-targeted theranostics fibroblast activation protein RADIOPHARMACEUTICALS
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部